Gerald W. McLaughlin
CIK: 0001495412
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALLR
Allarity Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About McLaughlin Gerald W.
McLaughlin Gerald W. (SEC CIK 0001495412) files insider reports with the SEC as Director of Allarity Therapeutics, Inc. (ALLR).
Signal8 holds 3 ownership filings by McLaughlin Gerald W., all Form 4s, filed between Jan 24, 2025 and May 7, 2026. Those filings report 3 transactions, from Jan 22, 2025 to Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McLaughlin Gerald W.'s filings is in BOSTON, MA.
Recent filings by McLaughlin Gerald W.
Other insiders filing for Allarity Therapeutics, Inc. (ALLR)
- Graff Jeremy R.
- Jensen Thomas, CEO
- Hoeiland Jesper, Director
- Ervin Jeffrey S, CFO
- Vazzano Joseph Walter, Director
- Benjamin Laura, Director